Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 94

Sort by

Sort Order Select

Journal Articles

CD22-Directed CAR T-Cell Therapy for Large B-Cell Lymphomas Progressing after CD19-Directed CAR T-Cell Therapy: Continued Durable Remissions at 3-Year Follow-up

Blood (2024) 144 (Supplement 1): 69.

https://doi.org/10.1182/blood-2024-198544

Published: 2024

Journal Articles

Immunoglobulin Sequencing Biologically Distinguishes B-Lymphoblastic Lymphoma from Acute Lymphoblastic Leukemia and Reveals a Spectrum of Disease Dissemination across Clinical Stages

Carol Fries Simpson, Lik Wee Lee, Hongyue Wang, Diana G. Adlowitz, Philip Rock, Brent L. Wood, Rachel E. Rau, Kara L. Davis, Anne Angiolillo, Meenakshi Devidas, David T. Teachey, Karen R Rabin, Birte Wistinghausen, Donald Barkauskas, Robert J. Hayashi, Richard Burack, Carl E Allen, Michelle L. Hermiston, Ilan R. Kirsch

Blood (2024) 144 (Supplement 1): 2838.

https://doi.org/10.1182/blood-2024-201634

Published: 2024

Journal Articles

Towards Remote Monitoring of Sickle Cell Disease for Heart Failure: A Single Lead ECG-AI Model

Ibrahim Karabayir, Robert L. Davis, Lokesh Chinthala, Parul Rai, Dan McGuire, Jane S Hankins, Oguz Akbilgic

Blood (2024) 144 (Supplement 1): 5064.

https://doi.org/10.1182/blood-2024-209315

Published: 2024

Journal Articles

Impact of Luspatercept on Healthcare Resource Use (HCRU) Among Patients with Lower-Risk, Myelodysplastic Syndromes (LR-MDS): A Medical Record Review in Canada, Germany, and Spain

Maria Diez-Campelo, Elizabeth Esterberg, Ravi K. Goyal, Mrudula B. Glassberg, Aylin Yucel, Julien Rombi, Keith L. Davis, Maria Jimenez, Dimana Miteva, Ahmed Hnoosh, Ulrich Germing

Blood (2024) 144 (Supplement 1): 5055.

https://doi.org/10.1182/blood-2024-206948

Published: 2024

Journal Articles

Machine Learning Approach for Analysis of Metabolomics Predicts Persistent Albuminuria in Patients with Sickle Cell Anemia

Akram Mohammed, Laila Elsherif, Vimal K. Derebail, E. Diane Wallace, Brandie M. Ehrmann, Berna Bakir-Batu, Kammie L. Patillo, David Wichlan, Kristina Landes, Paula McCune, Robert M. Cronin, Payal C. Desai, Jeffrey Macdonald, Robert L. Davis, Kenneth I. Ataga

Blood (2024) 144 (Supplement 1): 7487.

https://doi.org/10.1182/blood-2024-206660

Published: 2024

Journal Articles

CD22-Directed CAR T-Cell Therapy Achieves Complete Remission in CD19-Directed CAR T-Cell Refractory Follicular and Mantle Cell Lymphoma

Blood (2024) 144 (Supplement 1): 2064.

https://doi.org/10.1182/blood-2024-198489

Published: 2024

Journal Articles

Genomic Biomarkers of Poor Outcome in Patients with T-Cell Lymphoblastic Lymphoma

Blood (2024) 144 (Supplement 1): 313.

https://doi.org/10.1182/blood-2024-203827

Published: 2024

Journal Articles

TCL1A Is Associated with Blinatumomab Response and Immune Activation in Pediatric B-ALL

Blood (2024) 144 (Supplement 1): 634.

https://doi.org/10.1182/blood-2024-203756

Published: 2024

Journal Articles

Prior Knowledge Integration Improves Relapse Prediction and Identifies Relapse Associated Mechanisms in Childhood B Cell Acute Lymphoblastic Leukemia

Abhishek Vallabhbhai Koladiya, Astraea Jager, Anthony Culos, Milton Merchant, Yuxuan Liu, Lucille Stuani, Jolanda Sarno, Pablo Domizi, Charles G. Mullighan, Nima Aghaeepour, Sean Bendall, Kara L. Davis

Blood (2023) 142 (Supplement 1): 1603.

https://doi.org/10.1182/blood-2023-187264

Published: 2023

Journal Articles

Enrichment in Metabolic Pathway Activation Corresponds to Immunoglobulin Gene Diversity across B Cell Developmental Stages in B-Lymphoblastic Leukemia

Carol Fries Simpson, Yuxuan Liu, Lucille Stuani, Astraea Jager, Cameron Baker, Diana G. Adlowitz, Philip J Rock, Richard Burack, Kara L. Davis

Blood (2023) 142 (Supplement 1): 2972.

https://doi.org/10.1182/blood-2023-189313

Published: 2023

Journal Articles

Uridine Synthesis Is the Metabolic Vulnerability in Relapse-Associated B-ALL Cells with Active Pre-BCR Signaling

Yuxuan Liu, Haowen Jiang, Lucille Stuani, Jolanda Sarno, Pablo Domizi, Milton Merchant, Dorra Jedoui, Astraea Jager, Min Huang, Norman J. Lacayo, Kathleen M. Sakamoto, Jiangbin Ye, Kara L. Davis

Blood (2023) 142 (Supplement 1): 4340.

https://doi.org/10.1182/blood-2023-186925

Published: 2023

Journal Articles

CD22 CAR T Cell-Related IEC-HS Is Associated with an IFN-γ Cytokine Signature

Hrishikesh Srinagesh, John H. Baird, Neha Agarwal, Yi-Jiun Su, Anne Marijn Kramer, Agnes Reschke, Nikeshan Jeyakumar, Sushma Bharadwaj, Liora Michal Schultz, Sneha Ramakrishna, Kara L. Davis, Bita Sahaf, Steven Feldman, Crystal L. Mackall, David B. Miklos, Lori S. Muffly, Matthew J. Frank

Blood (2023) 142 (Supplement 1): 4839.

https://doi.org/10.1182/blood-2023-178283

Published: 2023

Journal Articles

Patient Characteristics, Treatment Patterns, and Health Outcomes in a Real-World Population of Patients with Myelofibrosis Treated with Fedratinib

Francesco Passamonti, Rohan C. Parikh, Siddhi Korgaonkar, Manoj Chevli, Samantha Slaff, Julien Rombi, Basirat Adeyemi, Keith L. Davis, Aylin Yucel

Blood (2023) 142 (Supplement 1): 2425.

https://doi.org/10.1182/blood-2023-173420

Published: 2023

Journal Articles

Going Going Gonad: Assessing Iron Staining Impact on Fertility for Patients with Sickle Cell Disease

Mahvish Q. Rahim, Derrick L. Goubeaux, Seethal A Jacob, Amanda C. Zielen, Kyle E. Orwig, Jessica L. Davis, Amanda J Saraf

Blood (2023) 142 (Supplement 1): 5343.

https://doi.org/10.1182/blood-2023-181787

Published: 2023

Journal Articles

Project Evolve, Evaluation of Lineage Switch (LS), an International Initiative: Preliminary Results Reveal Dismal Outcomes in Patients with LS

Sara K. Silbert, Cynthia Harrison, D. Nathan Biery, Alexandra Semchenkova, Elena Zerkalenkova, Anna Alonso-Saladrigues, Kaylyn Utley, Ibrahim Aldoss, Liping Zhao, Sneha Fernandes, Jeremy D. Rubinstein, Naomi Torres Carapia, Bill H. Chang, Anant Vatsayan, Barbara De Moerloose, Holly L. Pacenta, Dennis John Kuo, Gabriele Escherich, Benjamin J. Lee, Michele S. Redell, Mandi R. Fitzjohn, Daniel P. Larson, Nicolas Duployez, Raymund S. Cuevo, Rui Rochelle He, David Dickens, Firas El Chaer, Kelly Reed, Matthias Wolfl, Sunil S. Raikar, Süreyya Savaşan, Latika Puri, Zhubin J. Gahvari, Aimee C. Talleur, Hisham Abdel-Azim, Aghiad Chamdin, Marlie R.M. Provost, Vanessa A. Fabrizio, Kerstin Mezger, Alexandra McLean Stevens, Emily M. Hsieh, Hao-Wei Wang, Constance M. Yuan, Ulrich A. Duffner, Jing Pan, Sara Ghorashian, Susana Rives, Chloe Hoang, Kara L. Davis, Elad Jacoby, Alexander Popov, Adam Lamble, Nirali N. Shah

Blood (2023) 142 (Supplement 1): 4202.

https://doi.org/10.1182/blood-2023-182293

Published: 2023

Journal Articles

Machine Learning Predicts Acute Kidney Injury in Hospitalized Patients with Sickle Cell Disease

Rima Zahr, Akram Mohammed, Surabhi Naik, Daniel Faradji, Jeffrey D. Lebensburger, Kenneth I Ataga, Robert L Davis

Blood (2022) 140 (Supplement 1): 2530–2531.

https://doi.org/10.1182/blood-2022-165572

Published: 2022

Journal Articles

CD22 CAR T Cells Demonstrate Favorable Safety Profile and High Response Rates in Pediatric and Adult B-ALL: Results of a Phase 1b Study

Nikeshan Jeyakumar, Sneha Ramakrishna, Matthew J Frank, Bita Sahaf, Steven A. Feldman, David B. Miklos, Crystal L. Mackall, Kara L. Davis, Lori Muffly, Liora M. Schultz

Blood (2022) 140 (Supplement 1): 2374–2375.

https://doi.org/10.1182/blood-2022-164456

Published: 2022

Journal Articles

Plasma Microbial Cell-Free DNA to Characterize Infection Vs Cytokine Release Syndrome in Pediatric Patients with B ALL after CAR T Cell Therapy

Catherine Aftandilian, Xue Rachel Bito, David M. Berman, Radha Duttagupta, Kara L. Davis

Blood (2022) 140 (Supplement 1): 4681–4683.

https://doi.org/10.1182/blood-2022-163662

Published: 2022

Journal Articles

Long-Term Follow-up of CD19/22 CAR Therapy in Children and Young Adults with B-ALL Reveals Efficacy, Tolerability and High Survival Rates When Coupled with Hematopoietic Stem Cell Transplantation

Blood (2022) 140 (Supplement 1): 10300–10302.

https://doi.org/10.1182/blood-2022-167789

Published: 2022

Journal Articles

Improved Relapse Prediction in Pediatric Acute Myeloid Leukemia By Deconvolving Lineage-Specific and Cancer-Specific Features in Single-Cell Data

Timothy James Keyes, Astraea Jager, Michael Krueger, Sylvia Plevritis, Robert Tibshirani, Richard Aplenc, Garry P. Nolan, Michele S. Redell, Kara L. Davis

Blood (2022) 140 (Supplement 1): 6288–6289.

https://doi.org/10.1182/blood-2022-170939

Published: 2022

NARROW

CD22-Directed CAR T-Cell Therapy for Large B-Cell Lymphomas Progressing after CD19-Directed CAR T-Cell Therapy: Continued Durable Remissions at 3-Year Follow-up

Immunoglobulin Sequencing Biologically Distinguishes B-Lymphoblastic Lymphoma from Acute Lymphoblastic Leukemia and Reveals a Spectrum of Disease Dissemination across Clinical Stages

Towards Remote Monitoring of Sickle Cell Disease for Heart Failure: A Single Lead ECG-AI Model

Impact of Luspatercept on Healthcare Resource Use (HCRU) Among Patients with Lower-Risk, Myelodysplastic Syndromes (LR-MDS): A Medical Record Review in Canada, Germany, and Spain

Machine Learning Approach for Analysis of Metabolomics Predicts Persistent Albuminuria in Patients with Sickle Cell Anemia

CD22-Directed CAR T-Cell Therapy Achieves Complete Remission in CD19-Directed CAR T-Cell Refractory Follicular and Mantle Cell Lymphoma

Genomic Biomarkers of Poor Outcome in Patients with T-Cell Lymphoblastic Lymphoma

TCL1A Is Associated with Blinatumomab Response and Immune Activation in Pediatric B-ALL

Prior Knowledge Integration Improves Relapse Prediction and Identifies Relapse Associated Mechanisms in Childhood B Cell Acute Lymphoblastic Leukemia

Enrichment in Metabolic Pathway Activation Corresponds to Immunoglobulin Gene Diversity across B Cell Developmental Stages in B-Lymphoblastic Leukemia

Uridine Synthesis Is the Metabolic Vulnerability in Relapse-Associated B-ALL Cells with Active Pre-BCR Signaling

CD22 CAR T Cell-Related IEC-HS Is Associated with an IFN-γ Cytokine Signature

Patient Characteristics, Treatment Patterns, and Health Outcomes in a Real-World Population of Patients with Myelofibrosis Treated with Fedratinib

Going Going Gonad: Assessing Iron Staining Impact on Fertility for Patients with Sickle Cell Disease

Project Evolve, Evaluation of Lineage Switch (LS), an International Initiative: Preliminary Results Reveal Dismal Outcomes in Patients with LS

Machine Learning Predicts Acute Kidney Injury in Hospitalized Patients with Sickle Cell Disease

CD22 CAR T Cells Demonstrate Favorable Safety Profile and High Response Rates in Pediatric and Adult B-ALL: Results of a Phase 1b Study

Plasma Microbial Cell-Free DNA to Characterize Infection Vs Cytokine Release Syndrome in Pediatric Patients with B ALL after CAR T Cell Therapy

Long-Term Follow-up of CD19/22 CAR Therapy in Children and Young Adults with B-ALL Reveals Efficacy, Tolerability and High Survival Rates When Coupled with Hematopoietic Stem Cell Transplantation

Improved Relapse Prediction in Pediatric Acute Myeloid Leukemia By Deconvolving Lineage-Specific and Cancer-Specific Features in Single-Cell Data

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only